Tag: strategic partnerships
-
Oncosyne Expands Functional Precision Oncology into Esophageal Cancer
Oncosyne has expanded its functional precision oncology programme into esophageal cancer, with the first patients now recruited and patient-derived tumoroids successfully growing in the laboratory. The milestone is part of the ExPDT study and a collaboration with the surgical team of Dr. Jan Johansson and Dr. Oscar Åkesson at Skåne University Hospital. The study aims…
-
Oncosyne Advances Pancreatic Cancer Models with Organ-on-a-Chip Technology
Oncosyne is developing a next-generation organ-on-a-chip co-culture module for pancreatic cancer through the INVICTA project, funded by The Research Council of Norway. The project brings together Oncosyne, Professor Elena Rangelova at Sahlgrenska University Hospital, and Professor Stefan Krauss Deiml at the Hybrid Technology Hub (HTH), University of Oslo. The new module is based on HTH’s pump-less,…
-
Oncosyne Expands Pancreatic Cancer Patient Cohort to Strengthen Translational Research
Oncosyne has expanded the clinical study within the INVICTA project to include both chemotherapy-naïve and chemotherapy-treated patients with pancreatic cancer. The expanded study broadens the diversity of patient samples available for research and accelerates the growth of a clinically and molecularly annotated biobank of patient-derived pancreatic cancer tumoroids. Developed in collaboration with Sahlgrenska University Hospital…
-
Aarti Kapoor Joins Oncosyne as Strategic Partnerships Director
Oncosyne is pleased to announce that Aarti Kapoor has joined the company as Strategic Partnerships Director. Aarti brings more than 15 years of international experience across biotech, medtech, and pharma analytics, with a career dedicated to bridging scientific innovation and commercial execution. She has worked extensively with R&D-driven organizations across Europe, the United States, and…